Skip to content
DefDex

Federal award

ORTHO-CLINICAL DIAGNOSTICS GMBH

W9114F12C0002

Contract

Obligated and Ceiling

Obligated (net)
$601,573.08
Ceiling (potential value, not spending)
$601,573.08
Current value
$601,573.08
Gross positive obligations
$612,562.12

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
ORTHO-CLINICAL DIAGNOSTICS GMBH · GM5SLSX6DLH5
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
ORTHO-CLINICAL DIAGNOSTICS GMBH · UFSGLEADKBC1
Awarding agency
Department of War · sub-agency 2100 · office W9114F
Funding agency
Department of War · sub-agency 2100
Product or service (PSC)
6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
Industry (NAICS)
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
PIID
W9114F12C0002
Award type code
D
Actions
10 · Apr 18, 2012 to Feb 8, 2019
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History10

Award actions
DateFYModAction typeObligationCompany in company totals
Feb 8, 2019FY2019P00010B−$1,961.88
—
Aug 15, 2017FY2017P00009M$5,626.21
—
Jun 12, 2017FY2017P00008K−$7,428.29
—
Mar 16, 2015FY2015P00007G$130,336.09
—
Feb 28, 2014FY2014P00006G$140,321.95
—
Feb 25, 2014FY2014P00004F$0.00
—
Feb 6, 2014FY2014P00003B−$1,598.87
—
May 24, 2013FY2013P00002B$0.00
—
Feb 28, 2013FY2013P00001G$171,809.44
—
Apr 18, 2012FY20120—$164,468.43
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.